Zentalis Pharmaceuticals, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Gallagher Cam | President | Sale | 8,501 | $19.96 | $169,680 | 491,270 | Feb 13, 2023 |
| Bunker Kevin D. | Chief Scientific Officer | Sale | 6,500 | $19.98 | $129,870 | 865,157 | Feb 13, 2023 |
| Gallagher Cam | President | Sale | 9,428 | $22.22 | $209,490 | 503,675 | Feb 6, 2023 |
| Bunker Kevin D. | Chief Scientific Officer | Gift | 30,000 | — | — | 784,110 | Feb 1, 2023 |
| Gallagher Cam | President | Award / Grant | 161,092 | — | — | 513,103 | Feb 1, 2023 |
| Blackwell Kimberly | Chief Executive Officer | Award / Grant | 244,800 | — | — | 249,800 | Feb 1, 2023 |
| Epperly Melissa B, | Chief Financial Officer | Award / Grant | 101,957 | — | — | 399,899 | Feb 1, 2023 |
| Paul Andrea | General Counsel | Award / Grant | 40,783 | — | — | 40,783 | Feb 1, 2023 |
| Brownstein Carrie | Chief Medical Officer | Award / Grant | 16,313 | — | — | 116,313 | Feb 1, 2023 |
| Gallagher Cam | President | Sale | 500 | $24.87 | $12,435 | 352,011 | Jan 17, 2023 |
| Gallagher Cam | President | Sale | 300 | $21.46 | $6,438 | 362,011 | Jan 5, 2023 |
| Gallagher Cam | President | Sale | 900 | $23.48 | $21,132 | 372,011 | Nov 15, 2022 |
| Gallagher Cam | President | Sale | 157 | $24.24 | $3,806 | 396,885 | Nov 7, 2022 |
| Gallagher Cam | President | Sale | 12,500 | $23.51 | $293,875 | 409,385 | Oct 17, 2022 |
| Gallagher Cam | President | Sale | 5,496 | $22.83 | $125,474 | 431,885 | Oct 5, 2022 |
| Epperly Melissa B, | Chief Financial Officer | Award / Grant | 50,000 | — | — | 297,543 | Oct 3, 2022 |
| Bunker Kevin D. | Chief Scientific Officer | Award / Grant | 50,000 | — | — | 814,110 | Oct 3, 2022 |
| Brownstein Carrie | Chief Medical Officer | Award / Grant | 100,000 | — | — | 100,000 | Oct 3, 2022 |
| Gallagher Cam | President | Sale | 4,074 | $25.59 | $104,254 | 454,385 | Sep 16, 2022 |
| Skvarka Jan | — | Award / Grant | 36,606 | — | — | 36,606 | Sep 9, 2022 |
| Bunker Kevin D. | Chief Operating Officer | Sale | 5,000 | $30.00 | $150,000 | 95,000 | Aug 10, 2022 |
| Bunker Kevin D. | Chief Operating Officer | Sale | 5,000 | $30.00 | $150,000 | 100,000 | Jul 20, 2022 |
| Bunker Kevin D. | Chief Operating Officer | Sale | 3,290 | $30.01 | $98,733 | 105,000 | Jul 13, 2022 |
| Bunker Kevin D. | Chief Operating Officer | Sale | 25,000 | $30.07 | $751,750 | 110,000 | Jul 5, 2022 |
| Johnson David Michael | — | Award / Grant | 24,871 | — | — | 108,330 | Jun 8, 2022 |
| Kariuki Enoch | — | Award / Grant | 21,817 | — | — | 21,817 | Jun 8, 2022 |
| Gallagher Cam | President | Award / Grant | 111,072 | — | — | 466,885 | May 30, 2022 |
| Bunker Kevin D. | Chief Operating Officer | Sale | 100 | $33.16 | $3,316 | 135,000 | Apr 11, 2022 |
| SUN ANTHONY Y | President & CEO | Sale | 10,471 | $48.50 | $507,844 | 1,186,060 | Apr 5, 2022 |
| Gallagher Cam | — | Sale | 3,335 | $50.68 | $169,018 | 358,109 | Apr 5, 2022 |
| Epperly Melissa B, | Chief Financial Officer | Sale | 8,094 | $48.75 | $394,583 | 256,400 | Apr 4, 2022 |
| Bunker Kevin D. | Chief Operating Officer | Sale | 4,444 | $49.50 | $219,978 | 140,000 | Mar 21, 2022 |
| Gallagher Cam | — | Sale | 4,578 | $41.45 | $189,758 | 371,235 | Mar 15, 2022 |
| Bunker Kevin D. | Chief Operating Officer | Sale | 4,301 | $47.18 | $202,921 | 151,699 | Mar 10, 2022 |
| Gallagher Cam | — | Sale | 9,477 | $44.90 | $425,517 | 376,336 | Mar 7, 2022 |
| SUN ANTHONY Y | President & CEO | Sale | 700 | $50.91 | $35,637 | 1,196,531 | Mar 1, 2022 |
| Epperly Melissa B, | Chief Financial Officer | Sale | 702 | $49.59 | $34,812 | 264,494 | Feb 23, 2022 |
| Bunker Kevin D. | Chief Operating Officer | Sale | 6,343 | $48.95 | $310,490 | 162,857 | Feb 22, 2022 |
| Gallagher Cam | — | Sale | 5,366 | $52.15 | $279,837 | 387,183 | Feb 15, 2022 |
| Voliotis Dimitris | SVP, Clinical Development | Award / Grant | 10,329 | — | — | 16,579 | Feb 14, 2022 |
| Pinto Alexis | Chief Legal Officer | Sale | 77 | $50.75 | $3,908 | 22,240 | Feb 14, 2022 |
| Bunker Kevin D. | Chief Operating Officer | Sale | 2,366 | $52.15 | $123,387 | 177,634 | Feb 10, 2022 |
| Epperly Melissa B, | Chief Financial Officer | Award / Grant | 16,405 | — | — | 266,407 | Feb 10, 2022 |
| Gallagher Cam | — | Sale | 4,850 | $50.17 | $243,325 | 395,813 | Feb 10, 2022 |
| SUN ANTHONY Y | President & CEO | Sale | 525 | $50.75 | $26,644 | 1,217,473 | Feb 10, 2022 |
| Gallagher Cam | — | Sale | 1,250 | $54.35 | $67,938 | 387,203 | Feb 7, 2022 |
| SUN ANTHONY Y | President & CEO | Sale | 100 | $59.31 | $5,931 | 1,182,246 | Feb 1, 2022 |
| Voliotis Dimitris | SVP, Clinical Development | Sale | 1,997 | $63.48 | $126,770 | 7,550 | Jan 20, 2022 |
| Bunker Kevin D. | Chief Operating Officer | Sale | 2,753 | $59.17 | $162,895 | 187,247 | Jan 20, 2022 |
| Gallagher Cam | — | Sale | 1,842 | $63.45 | $116,875 | 398,503 | Jan 18, 2022 |